4//SEC Filing
COHEN ALAIN J 4
Accession 0001209191-21-025662
CIK 0001662579other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:30 PM ET
Size
7.2 KB
Accession
0001209191-21-025662
Insider Transaction Report
Form 4
COHEN ALAIN J
Director10% Owner
Transactions
- Award
Common Stock
2021-04-05$37.51/sh+266$9,978→ 266 total
Holdings
- 1,719,332(indirect: See Footnote)
Common Stock
- 2,484,425(indirect: By Cobro Ventures Opportunity Fund, L.P.)
Common Stock
Footnotes (4)
- [F1]These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 5, 2021.
- [F3]Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001132946
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 4:30 PM ET
- Size
- 7.2 KB